Research Paper Volume 13, Issue 12 pp 16804—16815
Therapeutic targets and molecular mechanism of calycosin for the treatment of cerebral ischemia/reperfusion injury
Figure 6. Docking poses of calycosin on three identified targets. By using molecular docking analysis, the data demonstrated that effective binding capacities of calycosin with CIRI were identified in (A) TP53 (2MWO), (B) AKT1 (3O96), and (C) VEGFA (5T89) targets.